# The Clinical Efficacy of DFPP in Patients With AAGN

> **NCT02294344** · NA · TERMINATED · sponsor: **Zhi-Hong Liu, M.D.** · enrollment: 14 (actual)

## Conditions studied

- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

## Interventions

- **OTHER:** DFPP&CTX
- **DRUG:** CTX

## Key facts

- **NCT ID:** NCT02294344
- **Lead sponsor:** Zhi-Hong Liu, M.D.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The recruitment of subject is very difficult.
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294344, "The Clinical Efficacy of DFPP in Patients With AAGN". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02294344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*